It has been reported that endogenous agonists of TLR-4 were present in glomerular diseases that may induce podocyte dysfunction independent of TIL7/9 activation seen with endocytosed DNA and RNA immune complexes in SLE (38). Here, TLR4 is linked to systemic lupus erythematosus.